Bandingkan Harga & Kinerja Radiant Utama Interinsco Tbk. (RUIS) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Radiant Utama Interinsco Tbk. dan Organon Pharma Indonesia Tbk.: Radiant Utama Interinsco Tbk. diperdagangkan di Rp212 (kapitalisasi pasar 160,16 M, volume 24 jam 5,69 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Radiant Utama Interinsco Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| RUIS | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 160,16 M | 104,4 M |
Volume | 5,69 jt | — |
Lot | 56,9 rb | — |
Perputaran | 1,23 M | — |
Harga Rata-rata | 216,05 | — |
Nilai Transaksi | 1,23 M | — |
Harga Ekuilibrium Indikatif | 212 | — |
Volume Ekuilibrium Indikatif | 694 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Radiant Utama Interinsco Tbk.
PT Radiant Utama Interinsco (Company) was established base on notarial deed No.41 of Mr Hadi Moentoro, dated August 22, 1984. The deed of establishment was approved by the Ministry of Justice in its decision letter No. C2-574-HT.01.01.Th.85 dated Feb 11, 1985.The Company’s articles of association has been amended several times, most recently by notarial deed No. 28 of Mr. P. Soetrisno A. Tampubolon, S.H., dated Dec 19, 2005, concerning among others, the increasing paid up capital, increase authorized share, and change in the Company’s par value.PT Radiant Utama Interinsco (Company) was established base on notarial deed No.41 of Mr Hadi Moentoro, dated August 22, 1984. The deed of establishment was approved by the Ministry of Justice in its decision letter No. C2-574-HT.01.01.Th.85 dated Feb 11, 1985.The Company’s articles of association has been amended several times, most recently by notarial deed No. 28 of Mr. P. Soetrisno A. Tampubolon, S.H., dated Dec 19, 2005, concerning among others, the increasing paid up capital, increase authorized share, and change in the Company’s par value.
Selengkapnya di halaman RUIS →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
